![Geoffrey Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoffrey Parker
Directeur Financier/CFO chez
ALLOGENE THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Geoffrey M.
Parker is currently an Independent Director at Perrigo Co. Plc since 2016, a Director at Better Therapeutics LLC since 2021, and Chief Financial Officer & Executive Vice President at Allogene Therapeutics, Inc. starting in 2024.
Formerly, Mr. Parker was an Independent Director at ChemoCentryx, Inc. from 2009 to 2022, Independent Director at Sunesis Pharmaceuticals, Inc. from 2016 to 2017, Director at Genoptix, Inc., Independent Director at Genomic Health, Inc. from 2016 to 2019, Independent Director at Better Therapeutics, Inc. from 2021 to 2024, MD & Partner-Investment Banking Division at The Goldman Sachs Group, Inc. from 1997 to 2009, Chief Business Officer at InteKrin Therapeutics, Inc. from 2009 to 2010, Chief Financial Officer & Executive Vice President at Tricida, Inc. from 2020 to 2021, Vice President at Feibusch & Co., Inc. from 1995 to 1997, Chief Financial Officer & Executive Vice President at Anacor Pharmaceuticals LLC in 2015, and Chief Financial Officer & Senior Vice President at Anacor, Inc. from 2012 to 2015.
Education includes undergraduate studies at Dartmouth College and an MBA from Stanford Graduate School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 535 060 ( 0,16 % ) | 1 M $ | 31/05/2026 | |
PERRIGO CO. PLC 0,06 % | 12/06/2026 | 76 471 ( 0,06 % ) | 845 005 $ | 31/05/2026 |
Postes actifs de Geoffrey Parker
| Sociétés | Poste | Début |
|---|---|---|
| PERRIGO COMPANY PLC | Directeur/Membre du Conseil | 07/11/2016 |
| ALLOGENE THERAPEUTICS, INC. | Directeur Financier/CFO | 16/10/2023 |
Better Therapeutics LLC
 Better Therapeutics LLC Medical SpecialtiesHealth Technology Develops digital therapeutics for treating cardio-metabolic diseases | Directeur/Membre du Conseil | 30/03/2021 |
Anciens postes connus de Geoffrey Parker
| Sociétés | Poste | Fin |
|---|---|---|
| BETTER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 14/03/2024 |
| CHEMOCENTRYX, INC. | Directeur/Membre du Conseil | 20/10/2022 |
| GENOMIC HEALTH, INC. | Directeur/Membre du Conseil | 08/11/2019 |
| VIRACTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 31/12/2017 |
| ANACOR PHARMACEUTICALS INC | Directeur Financier/CFO | 31/05/2015 |
Formation de Geoffrey Parker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
The Goldman Sachs Group, Inc.
 The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Genoptix, Inc.
 Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Genomic Health, Inc.
 Genomic Health, Inc. Medical/Nursing ServicesHealth Services Engages in genomic-based diagnostic tests for overtreatment and optimal treatment of early stage cancer | Health Services |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
Tricida, Inc.
 Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
Feibusch & Co., Inc.
 Feibusch & Co., Inc. Investment ManagersFinance Operates as a venture capital firm | Finance |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Anacor, Inc.
 Anacor, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Perrigo Co. Plc
 Perrigo Co. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Better Therapeutics LLC
Better Therapeutics LLC Medical SpecialtiesHealth Technology Develops digital therapeutics for treating cardio-metabolic diseases | Health Technology |
Better Therapeutics, Inc.
 Better Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases | Health Technology |
Choisissez Zonebourse 
